Close Menu
The Business TimesThe Business Times
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
What's On
Wales school to close as outbreak of vomiting illness impacts hundreds of pupils

Wales school to close as outbreak of vomiting illness impacts hundreds of pupils

7 December 2025
Car tax reduced to £0 for these drivers – see full list of exemptions

Car tax reduced to £0 for these drivers – see full list of exemptions

7 December 2025
Prince William to follow in Diana’s footsteps and take George to help the homeless

Prince William to follow in Diana’s footsteps and take George to help the homeless

7 December 2025
Mum bags M&S shopping for £2.96 instead of £29.55

Mum bags M&S shopping for £2.96 instead of £29.55

7 December 2025
Fulcrum Therapeutics, Inc. (FULC) Discusses New Clinical Data From the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease Transcript

Fulcrum Therapeutics, Inc. (FULC) Discusses New Clinical Data From the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease Transcript

7 December 2025
Facebook X (Twitter) Instagram
Business Sunday, Dec 7
The Business TimesThe Business Times
Newsletter
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
The Business TimesThe Business Times
Home » ZenaTech: Limited Resources To Keep Acquiring New Companies (NASDAQ:ZENA)
News

ZenaTech: Limited Resources To Keep Acquiring New Companies (NASDAQ:ZENA)

thebusinesstimes.co.ukBy thebusinesstimes.co.uk20 October 20251 Views
Facebook Twitter LinkedIn Reddit Telegram WhatsApp Pinterest Tumblr VKontakte Email
ZenaTech: Limited Resources To Keep Acquiring New Companies (NASDAQ:ZENA)
Share
Facebook Twitter LinkedIn Pinterest Email

This article was written by

With combined experience of covering technology companies on Wall Street and working in Silicon Valley, and serving as an outside adviser to several seed-round startups, Gary Alexander has exposure to many of the themes shaping the industry today. He has been a regular contributor on Seeking Alpha since 2017. He has been quoted in many web publications and his articles are syndicated to company pages in popular trading apps like Robinhood.

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram WhatsApp

Related Articles

Wales school to close as outbreak of vomiting illness impacts hundreds of pupils

Wales school to close as outbreak of vomiting illness impacts hundreds of pupils

Prince William to follow in Diana’s footsteps and take George to help the homeless

Prince William to follow in Diana’s footsteps and take George to help the homeless

Fulcrum Therapeutics, Inc. (FULC) Discusses New Clinical Data From the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease Transcript

Fulcrum Therapeutics, Inc. (FULC) Discusses New Clinical Data From the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease Transcript

Massive fire rips through 182-year-old church as flames cause tragic collapse

Massive fire rips through 182-year-old church as flames cause tragic collapse

Average Retirement Plans Can Be Risky: Why Income Investing Is The Practical Solution

Average Retirement Plans Can Be Risky: Why Income Investing Is The Practical Solution

‘Laughter and song will fill my Christmas even though it may be my last’

‘Laughter and song will fill my Christmas even though it may be my last’

UIVM: Unconvincing Blend Of Value And Momentum (NASDAQ:UIVM)

UIVM: Unconvincing Blend Of Value And Momentum (NASDAQ:UIVM)

UK snow forecast for Christmas as Met Office and BBC issue latest predictions

UK snow forecast for Christmas as Met Office and BBC issue latest predictions

BST: Technology Options CEF With 7.3% Yield, Growth, No Leverage, But Volatility

BST: Technology Options CEF With 7.3% Yield, Growth, No Leverage, But Volatility

Editors Picks
Car tax reduced to £0 for these drivers – see full list of exemptions

Car tax reduced to £0 for these drivers – see full list of exemptions

7 December 2025
Prince William to follow in Diana’s footsteps and take George to help the homeless

Prince William to follow in Diana’s footsteps and take George to help the homeless

7 December 2025
Mum bags M&S shopping for £2.96 instead of £29.55

Mum bags M&S shopping for £2.96 instead of £29.55

7 December 2025
Fulcrum Therapeutics, Inc. (FULC) Discusses New Clinical Data From the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease Transcript

Fulcrum Therapeutics, Inc. (FULC) Discusses New Clinical Data From the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease Transcript

7 December 2025

Subscribe to News

Get the latest finance and business news and updates directly to your inbox.

Latest Posts
Massive fire rips through 182-year-old church as flames cause tragic collapse

Massive fire rips through 182-year-old church as flames cause tragic collapse

7 December 2025
Young people to have benefits cut if they refuse job offer in new DWP crackdown

Young people to have benefits cut if they refuse job offer in new DWP crackdown

7 December 2025
Average Retirement Plans Can Be Risky: Why Income Investing Is The Practical Solution

Average Retirement Plans Can Be Risky: Why Income Investing Is The Practical Solution

7 December 2025
Facebook X (Twitter) Pinterest WhatsApp TikTok Instagram
© 2025 The Business Times. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.